• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    BMP Medical Expands Sterling, Massachusetts Facility

    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy

    Environmental Sustainability Becoming Increasingly Important to Medtech Industry

    Duane DiFranco Joins Harvard MedTech’s Medical Advisory Board

    Lionel Bonte Named President of Mativ’s Healthcare and Wellness Business Unit
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    JBC Technologies

    NDH Medical Inc.

    Fusion Biotec Inc.

    Arthur G. Russell Co. Inc., The

    Medbio LLC
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    JBC Technologies

    NDH Medical Inc.

    Fusion Biotec Inc.

    Arthur G. Russell Co. Inc., The

    Medbio LLC
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    J&J-Jabil Deal Truly Is Transformative for the Medtech Supply Chain

    On Aug. 2, 2018 Johnson & Johnson announced a reorganization of its Medical Devices division.

    J&J-Jabil Deal Truly Is Transformative for the Medtech Supply Chain
    Related CONTENT
    • Jabil
    • $150k NICU Medical Device Competition Finalists Announced
    • The 2019 Top 30 Global Medical Device Companies
    • 2. Johnson & Johnson
    • Verb Surgical Appoints New CEO
    Tony Freeman, President, A.S. Freeman Advisors LLC09.06.19
    Many medtech supply chain company managers spend time, effort, and worry to obtain their next big customer. Increasingly, their competition for these opportunities are global contract manufacturers whose roots are in the electronics industry. Johnson & Johnson’s Medical Device unit signaled an epic shift toward these multi-billion dollar international suppliers in transferring a large percentage of its manufacturing capability to Jabil Inc. last summer. The Jabil transaction is often unremarked by longtime medical device specialists, yet it should draw focus as the economics point to shifts in the profit margins of the medtech industry. Additionally, there is the possibility that these manufacturing behemoths will, over time, shift the procurement for device components from traditional North American and European suppliers to Asian firms where global contract manufacturers have the local infrastructure to ensure both low prices and good quality.

    On Aug. 2, 2018 Johnson & Johnson announced a reorganization of its Medical Devices division. In addition to job cuts, the company stated it had entered into a collaboration with the global contract manufacturer Jabil. The collaboration covered the manufacture of products for J&J’s DePuy Synthes (orthopedic) and Ethicon Endo (minimally invasive surgical devices) business units. J&J expected these actions would save the firm between $600 million and $800 million annually by early 2022. In September 2018, Jabil confirmed rumors that began circulating during the summer—i.e., 14 J&J manufacturing plants in the United States, Germany, and Switzerland would be transferred to Jabil, along with 6,000 J&J employees. In 2019, Jabil reported it had paid $153 million for the facilities, subject to certain adjustments. Though the purchase price sets no records, the deal is the largest transfer of manufacturing capability from an OEM to a supplier in the history of medical device manufacturing. It also marks a major turn in the types of companies that will dominate the medical device supply chain for years to come.

    At first glance, $24 billion Jabil is an unlikely manufacturing partner for orthopedic and endoscopic devices. Founded in 1966 in Detroit, Jabil forged its reputation as a contract manufacturer in the electronics industry, serving customers such as Apple, Cisco, and Hewlett-Packard. Fierce competition with other large contract manufacturers like Flextronics drove Jabil to open facilities in 30 countries as well as mastering international supply chains. Jabil’s electronics focus led it to focus on the consumer and office products, telecommunications, and automotive markets. Over time, Jabil brought in a few healthcare companies as customers but their decade-plus relationship with J&J was the cornerstone of their life sciences work. Surprisingly, most of Jabil’s J&J work was for CNC machining and molding rather than electronics.

    Transactions require rationale from both the buyer and the seller. Jabil’s reasons for acquiring a significant percentage of J&J Medical Devices’ manufacturing capability has to do with the razor-thin profit margins afforded in the other industries it serves. In 2018, Jabil had a 7.7 percent gross margin and a 3.5 percent operating margin. For those unfamiliar with accounting metrics, these margins are very low and are comparable to the margins of commodity auto parts suppliers. Most medical device supply chain companies earn two to four times more per dollar of revenue than Jabil, a company with 100-plus facilities. With the J&J deal and associated manufacturing contracts, Jabil can expect higher profitability on what it projects will be $1 billion per year in revenue by 2021. Jabil management has projected relevant operating margins to rise to 6 percent or better, still well under medical device averages.

    Higher margins are not the only reason global electronic contract manufacturers are intrigued with medical device work. The lifecycle of electronics products is brief. Many consumer devices are on the market for a year or less compared to four to seven years for medical products. Global CMs see the reduced selling, quoting, and setup times helping their bottom line. Jabil chief financial officer Michael Dastoor spoke favorably last fall about the predictable, reliable nature of the J&J work.

    J&J’s benefits from the transaction goes beyond immediate cost-savings, as it demonstrates a strategic shift by the world’s second largest medical device manufacturer. A significant portion of a large medtech OEM’s invested capital (the value of its stock and debt, less its cash) is in costly manufacturing facilities. Stepping away from investments in manufacturing should improve J&J’s Medical Devices’ return on invested capital while allowing the company to concentrate on its unique strengths—device design, marketing, sales, and distribution. These core capabilities often require less capital than manufacturing plants. J&J has improved a key investment metric while retaining access to the manufacturing services it requires. Additionally, J&J, like most large legacy OEMs, has notable overhead costs for each employee. Transferring manufacturing overhead to Jabil potentially makes J&J more competitive and profitable. In fairness, this point is speculative; no details of these costs have been publicly released.

    Supply chain company managers who have wrestled to meet their OEM customers’ requirements may question a diversified company with modest device experience succeeding in so grand a mission as being J&J’s largest medical device supplier. As a merger and acquisition specialist, I often see the greatest risk of a transaction is not in completing a deal but in the successful integration of an acquisition. To date, there is no evidence that Jabil has stumbled. Dividing the integration of the J&J facilities into three waves, Jabil expects the process to be complete this month (September 2019), only a few weeks beyond the original target date. Additionally, Jabil continues to project annual J&J revenues in the $1 billion range. While it has been a massive effort, the 14 facilities on two continents continue to supply J&J with core products in spite of new ownership.

    While it is too early to label the Jabil deal an unqualified success, the transaction is and will continue to be a benchmark event for the supply chain. Supply chain enthusiasts have long argued that any aspect of medical manufacturing can be outsourced. The Jabil deal is a powerful assertion that this view is correct. What is surprising to longtime pundits is that massive transfer of facilities, staff, and programs to a supply chain company went not to a multi-hundred million dollar rollup specializing in medical manufacturing, but to a multi-billion dollar company better known for its work outside the device world. While not putting to rest the strategies that have guided supply chain companies for the last two decades, it challenges the notion that high specialization is the single most important characteristic for success. J&J’s attraction appears to be based on Jabil’s scale and undeniable manufacturing expertise, supplemented by its understanding of J&J and medical devices. Considering J&J went ahead with a deal that encompasses many of its flagship products is a testament to the benefits such large-scale transactions might bring to other OEMs in the future.

    Jabil is not unique among global contract manufacturers. Flex has over $2 billion in healthcare revenues, mostly devices. Molex, Celestica, and Plexus also have life science portfolios north of $500 million. Were Jabil not selected as J&J’s outsource partner, these and other firms likely could have filled the role, albeit with significantly less elegance.

    A less apparent aspect of the transaction is Jabil’s global sourcing capability. The average medical device sold in developed nations contains content largely manufactured in those countries or a limited number of closely monitored low-cost of manufacture countries. Powerhouses of low-cost manufacturing like China, India, Malaysia, and Vietnam have been shunned due to quality concerns. It is not that Asian manufacturers cannot make components. The challenge has been for OEMs to have the teams in place in those countries to ensure a regular flow of parts manufactured to specification. Jabil and other contract manufacturers have the necessary sourcing teams in place in Asia to guarantee good parts at a lower cost than North American and European suppliers can provide. The trend may start with a few simple pieces but the thin margin ensures global suppliers will have strong incentive to expand their Asian sourcing, to the detriment of traditional component suppliers.

    Can established medical device supply chain companies compete with multi-billion dollar global players accustomed to operating on pennies? Strategic change may be necessary for survival. Strategies for thriving among behemoths include superior program management, specialization in complex or technically demanding aspects of devices, and demonstrated project nimbleness. Head-on competition is likely to prove costly and challenging.

    Established suppliers should re-examine their strategies in light of the Jabil transaction. J&J’s decision to outsource not only work but facilities and staff will be watched by other large OEMs. OEMs under $2 billion in sales have long outsourced most or all of their manufacturing. The model is not new, but the Jabil deal suggests the scale of the transfers and beneficiaries is changing. 


    Tony Freeman is president of A.S. Freeman Advisors LLC, an advisor on mergers and acquisitions in the specialty materials and precision manufacturing markets. Based in New York City, A.S. Freeman Advisors also provides corporate strategy, market planning, and valuation improvement consulting services. Tony can be contacted at tfreeman@asfreeman.com.
    Related Searches
    • change
    • Molding
    • it
    • sales
    Related Knowledge Center
    • Contract Manufacturing
    Suggested For You
    Jabil Jabil
    $150k NICU Medical Device Competition Finalists Announced $150k NICU Medical Device Competition Finalists Announced
    The 2019 Top 30 Global Medical Device Companies The 2019 Top 30 Global Medical Device Companies
    2. Johnson & Johnson 2. Johnson & Johnson
    Verb Surgical Appoints New CEO Verb Surgical Appoints New CEO
    Ethicon Receives FDA 510(k) Clearance for VISTASEAL Open and Laparoscopic Dual Applicator Devices Ethicon Receives FDA 510(k) Clearance for VISTASEAL Open and Laparoscopic Dual Applicator Devices
    Shape Memory Medical Names Chief Commercial Officer Shape Memory Medical Names Chief Commercial Officer
    J&J J&J's Ethicon Acquires Takeda's TachoSil Surgical Patch for $400M
    Results Announced From First In-Human Study of High Power-Short Duration Ablation Catheter Results Announced From First In-Human Study of High Power-Short Duration Ablation Catheter
    Biosense Webster Launches CARTONET at Heart Rhythm 2019 Biosense Webster Launches CARTONET at Heart Rhythm 2019
    J&J Helping Health Systems Address Clinician Burnout and Increase Employee Engagement J&J Helping Health Systems Address Clinician Burnout and Increase Employee Engagement
    The Evolution of Outsourcing The Evolution of Outsourcing
    Massachusetts Medical Device Development Center Names $200K Challenge Winners Massachusetts Medical Device Development Center Names $200K Challenge Winners
    Surgical Robotics Market to Surpass $24B by 2025 Surgical Robotics Market to Surpass $24B by 2025
    J&J Launches Contact Lenses with Transitions Light Intelligent Technology J&J Launches Contact Lenses with Transitions Light Intelligent Technology

    Related Buyers Guide Companies

    • Jabil

      Jabil

      ...
      Mary Edwards, Marketing Manager 11.16.22

    • Cardiovascular | Diagnostics | Neurological | Patient Monitoring | Surgical
      $150k NICU Medical Device Competition Finalists Announced

      $150k NICU Medical Device Competition Finalists Announced

      Keynote speakers for The MedTech Conference in Boston revealed.
      Children's National 09.06.19

    • The 2019 Top 30 Global Medical Device Companies

      The 2019 Top 30 Global Medical Device Companies

      ...
      Sean Fenske, Michael Barbella, & Sam Brusco, MPO Editorial Staff 07.30.19


    • 2. Johnson & Johnson

      2. Johnson & Johnson

      ...
      07.30.19

    • Surgical
      Verb Surgical Appoints New CEO

      Verb Surgical Appoints New CEO

      Kurt Azarbarzin most recently served as chief technology officer of ConMed.
      PR Newswire 07.25.19

    Loading, Please Wait..

    Trending
    • Study: Catheter Ablation Significantly Lowers Dementia Risk In AFib Patients
    • Tandem Diabetes Completes Deal For AMF Medical
    • BMP Medical Expands Sterling, Massachusetts Facility
    • The Future Of Biomedical Engineering Advancements
    • Abbott's Proclaim XR SCS OK'ed For Diabetic Neuropathy
    Breaking News
    • BMP Medical Expands Sterling, Massachusetts Facility
    • Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    • Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    • Duane DiFranco Joins Harvard MedTech’s Medical Advisory Board
    • Lionel Bonte Named President of Mativ’s Healthcare and Wellness Business Unit
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Vitamin D Supplementation Reduces Risk of Dynapenia
    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Multi-Strain Probiotic Improves Self-Reported Mood, Sleep, Serotonin Levels
    Coatings World

    Latest Breaking News From Coatings World

    Epoxytec Announces New Website Launch
    Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
    Axalta Releases Fourth Quarter and Full Year 2022 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    BMP Medical Expands Sterling, Massachusetts Facility
    Abbott's Proclaim XR SCS OK'ed for Diabetic Neuropathy
    Environmental Sustainability Becoming Increasingly Important to Medtech Industry
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pasithea Signs CMC Development and Manufacturing Agreement
    Experic Expands Analytical Capabilities and Facilities
    List Labs Expands Manufacturing Capacity
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
    TRESemmé Introduces New Pro Infusion Collection
    Walgreens Boots Alliance Shares 2022 ESG Report
    Happi

    Latest Breaking News From Happi

    KimChi Beauty Launches Spinning Hearts Love 02 Ahead of Valentine’s Day
    Dark & Lovely Names Actress Meagan Good Brand Ambassador
    Natural Household Care Company Tru Earth Adds Dishwasher Detergent Tablets
    Ink World

    Latest Breaking News From Ink World

    Xerox Releases 4Q, Full-Year 2022 Results
    Electronics For Imaging Names Frank Pennisi as CEO
    Fiery to Separate from EFI, Remain Wholly-Owned by Siris
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    EFI appoints Frank Pennisi CEO, Fiery now an independent business
    Bobst boosts senior sales team with Keith Nagle
    Penmar Industries adds Screen Truepress Jet L350UV SAI digital press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity’s Sales Grow
    Thinx to Pay up to $5 million to Settle Class Action Suit
    Typar Highlighting New Building Innovations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Launches the Mariner Deformity System
    Tyber Medical Hires 2 New Execs
    Miach Ortho Raises $40M in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Smart Devices with Privacy Focus Have More Consumer Appeal
    Siman Group Partners with SML to Unlock Full Retail Potential with RFID
    Brewer Science Presents Optics Integration Solutions at SPIE Photonics West

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login